ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

NCI Study Tests Method For Biomarker Validation

July 24, 2009

Abstracts Of Papers From Gynecologic Oncology Conference

October 10, 1975

Harlow, Abeloff To Chair BSC Subcommittees; Livingston To Head Extramural Advisors

September 15, 1995

ACS To Continue Supporting Both Treatment, Prevention Research, Leaders Say

May 1, 1987

Coooperative Groops Announce Two Sets of Mergers: NSABP, RTOG Form Alliance; CALGB, NCCTG & ACOSOG Seek to Become Single Group

March 11, 2011

Six Comprehensive Center Asked By Candlelighters For Pediatric Cancer

March 24, 1978